RT Journal Article
SR Electronic
T1 Estimating the Impact of Self-Management Education, Influenza Vaccines, Nebulizers, and Spacers on Healthcare Utilization and Expenditures for Medicaid-Enrolled Children with Asthma
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.28.20188466
DO 10.1101/2020.09.28.20188466
A1 Melike Yildirim
A1 Paul Griffin
A1 Pinar Keskinocak
A1 Jean O’Connor
A1 Julie L Swann
YR 2020
UL http://medrxiv.org/content/early/2020/09/29/2020.09.28.20188466.abstract
AB We quantify the effect of a set of interventions including asthma self-management education, influenza vaccination, spacers, and nebulizers on healthcare utilization and expenditures for Medicaid-enrolled children with asthma in New York and Michigan.Methods We obtained patients’ data from Medicaid Analytic eXtract files and evaluated patients with persistent asthma in 2010 and 2011. We used difference-in-difference regression to quantify the effect of the intervention on the probability of asthma-related healthcare utilization, asthma medication, and utilization costs. We estimated the average change in outcome measures from pre-intervention/intervention (2010) to post-intervention (2011) periods for the intervention group by comparing this with the average change in the control group over the same time horizon.Results All of the interventions reduced both utilization and asthma medication costs. Asthma self-management education, nebulizer, and spacer interventions reduced the probability of emergency department (20.8-1.5 %, 95%CI 19.7-21.9% vs. 0.5-2.5% respectively) and inpatient (3.5-0.8%, 95%CI 2.1-4.9% vs. 0.4-1.2%, respectively) utilizations. Influenza vaccine decreased the probability of primary care physician (6-3.5%, 95%CI 4.4-7.6% vs. 1.5-5.5%, respectively) visit. The reductions varied by state and intervention.Conclusions Promoting asthma self-management education, influenza vaccinations, nebulizers, and spacers can decrease the frequency of healthcare utilization and asthma-related expenditures while improving medication adherence.Competing Interest StatementThe authors have declared no competing interest.Funding StatementP. Griffin was supported by Regenstreif Center. P.Keskinocak received partial support from William W. George chair. J.Swann received partial support from A. Doug Allison chair.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The IRB that ruled on the ethics of our study was the Georgia Tech Institute Review Board (IRB) for Georgia Tech Research Corporation. Ethical approval was given by IRB for the research.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesMedicaid claims data were available at Georgia Tech through support by the Institute for People and Technology, Stewart School of Industrial and Systems Engineering, and Childrens Healthcare of Atlanta.